← All organizations

Ixaka

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 5, 2017

Timeline

2010s

Jun 1, 2015
Ixaka— Founded

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

rexmyelocel-t

Indications

Studied for

Recent trials (4)

NCT03111238Study directorPhase 3Apr 5, 2017
NCT03111238Lead sponsorPhase 3Apr 5, 2017
NCT03174522Study directorPhase 3Apr 5, 2017
NCT03174522Lead sponsorPhase 3Apr 5, 2017

Details

Founded: London, GB Jun 1, 2015
Last known activity: Apr 5, 2017

Notes

formerly Rexgenero Limited